Instituto Medico Europeo de la Obesidad
IMEO is a private Spanish medical clinic specializing in obesity treatment, offering surgical, endoscopic, and pharmacological interventions alongside multidisciplinary support. Founded in 1998, it operates in Madrid and Seville and has treated over 17,000 patients with a team of 25+ specialists.
- Company typePrivate
- Founded1998
- HeadquartersMadrid, Spain
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Instituto Medico Europeo de la Obesidad does
Instituto Médico Europeo de la Obesidad (IMEO) is a private Spanish medical clinic founded in 1998 that specializes in the treatment of obesity and overweight, operating as IMCOB18 S.L. Headquartered in Madrid with a satellite clinic in Seville, the company employs over 25 specialized professionals and self-reports having treated more than 17,000 patients over 25+ years. IMEO serves adult patients with overweight, obesity, and obesity-related metabolic conditions using a multidisciplinary model that combines surgeons, nutritionists, psychologists, physiotherapists, and aesthetic specialists, and self-positions as a leading reference center for obesity treatment in Spain and Europe.
IMEO's service portfolio spans surgical, endoscopic, and non-surgical interventions. Surgical procedures include Manga Gástrica (gastric sleeve), Bypass Gástrico, and the proprietary ByManga® technique that combines the advantages of sleeve and bypass. Endoscopic offerings include the Método Apollo Reforzado and the exclusive iBalón Secuencial — a sequential two-stage intragastric balloon protocol. Non-surgical options include standard Balón Gástrico, Banda Gástrica, GLP-1 pharmacological treatment, and the Programa Silueta diet and aesthetic program. Supporting diagnostics include a genetic obesity study, EIS interstitial electrical analysis, and TANITA body composition scanning. All surgical procedures are performed at Hospital Viamed Santa Elena under a partnership arrangement rather than at the clinic itself. The company also operates IMEO Academy, an international training program for surgeons in bariatric and endoscopic techniques.
IMEO operates a direct-to-consumer, self-pay business model. Pricing is not publicly disclosed and is provided upon consultation request, with financing options offered to patients. Treatment packages are structured as multi-year programs (e.g., 24-month comprehensive plans) that include pre-operative tests, surgical fees, hospital charges, and ongoing nutritional, psychological, and medical follow-up. Patient acquisition is driven by a content-marketing-led approach combining a blog on obesity topics, social media presence on Instagram, Facebook, and WhatsApp, patient testimonials, and direct phone/contact-form inquiries. Online scheduling is facilitated through a Calendly integration. The company has no public funding rounds, no institutional investors, no disclosed revenue, and no M&A activity in the available data.
Instituto Medico Europeo de la Obesidad firmographics
Firmographics- Name
- Instituto Medico Europeo de la Obesidad
- Legal name
- INSTITUTO MÉDICO DE LA CIRUGÍA DE LA OBESIDAD (IMCOB18 S.L.)
- Website
- https://imeoobesidad.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- IMEO is a private Spanish medical clinic specializing in obesity treatment, offering surgical, endoscopic, and pharmacological interventions alongside multidisciplinary support. Founded in 1998, it operates in Madrid and Seville and has treated over 17,000 patients with a team of 25+ specialists.
- Ownership category
- akta.pro rank
Instituto Medico Europeo de la Obesidad industry classification
Industry- Product category
- Bariatric Surgery & Obesity Treatment Services
- NAICS
- Diet and Weight Reducing Centers (812191), Educational Support Services (611710)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Obesity Medicine & Weight Management (HLAKADAL)
- akta.pro secondary industry
- Weight Loss Coaching (Non-Clinical) (HSADAFAB)
Keywords
Where Instituto Medico Europeo de la Obesidad is headquartered
LocationHeadquarters
- HQ city
- Madrid
- HQ country
- Spain
- HQ region
- Europe
Offices4 records
Markets served
Instituto Medico Europeo de la Obesidad business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Supply Chain, Infrastructure, Technology or R&D
Revenue model
- Bariatric Surgery Services: Revenue from surgical procedures including gastric sleeve (Manga Gástrica), gastric bypass, and other bariatric operations performed in Hospital Viamed Santa Elena. Includes pre-operative tests, medical fees, hospital charges, and post-operative follow-up.
- Endoscopic Treatments: Revenue from non-surgical procedures including gastric balloon (iBalón Secuencial), Method Apollo, and endoscopic treatments.
- Medical Consultations: Revenue from multidisciplinary consultations including nutrition, psychology, and medical follow-up services.
- Pharmacological Treatment: Revenue from GLP-1 pharmacological obesity treatments and ongoing medication management.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Multi-year contract | Manga Gástrica - 24-month comprehensive treatment program |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Instituto Medico Europeo de la Obesidad product offering
Product offeringCore offering
Instituto Médico Europeo de la Obesidad (IMEO) is a specialized obesity treatment clinic offering a comprehensive portfolio of surgical and non-surgical weight loss interventions. Core services include bariatric procedures (gastric sleeve, gastric bypass, ByManga®), endoscopic treatments (Método Apollo Reforzado, iBalón Secuencial), and complementary medical, nutritional, psychological, and pharmacological (GLP-1) support programs delivered through a multidisciplinary team.
Product overview
IMEO (Instituto Médico Europeo de la Obesidad) is a specialized obesity clinic offering a comprehensive portfolio of surgical and non-surgical weight loss treatments. The core offerings include surgical procedures such as Manga Gástrica (gastric sleeve), ByPass Gástrico, and ByManga® (combined approach), as well as endoscopic procedures like Método Apollo Reforzado and iBalón Secuencial. The clinic also provides non-surgical options including Balón Gástrico, Banda Gástrica, pharmacological treatments (GLP1), and the Programa Silueta for diet and aesthetic treatments. Additional services include advanced genetic studies for obesity, diabetes surgery, and international surgeon training through IMEO Academy. All treatments are supported by multidisciplinary follow-up including nutritionists, psychologists, physiotherapists, and aesthetic specialists.
Differentiator
Problem solved
Functional benefit
Brands
- ByManga®: Treatment combining advantages of Gastric Sleeve with benefits of Gastric Bypass.
- IMEO Academy
- iBalón Secuencial
- Método Apollo Reforzado
Products and services
- Manga Gástrica (Gastric Sleeve) Laparoscopic micro-surgery that reduces the stomach by approximately two-thirds for adult patients with obesity. The most effective bariatric treatment with a strong restrictive effect; includes pre-operative tests, hospital fees, and 24 months of nutritional and medical follow-up.
- Balón Gástrico (Gastric Balloon) Endoscopically inserted intragastric balloon kept in place for 6 months to 1 year, with nutritional and medical follow-up. For patients with overweight or moderate obesity who want a non-surgical weight loss option.
- Método Apollo Reforzado Proprietary endoscopic stomach reduction procedure without external scars, using EndoSleeve with Apollo suturing. Indicated for patients seeking a non-surgical, scarless, long-term weight loss solution.
- ByPass Gástrico (Gastric Bypass) Surgical procedure that reduces both stomach and intestine. Indicated for patients with morbid obesity who need a more aggressive combined restrictive and malabsorptive intervention.
- ByManga® Proprietary combined bariatric procedure integrating the advantages of gastric sleeve with the benefits of gastric bypass in a single operation. Indicated for patients needing a more comprehensive solution than sleeve alone.
- Cirugía de la Diabetes (Type II Diabetes Surgery) Laparoscopic bariatric microsurgery with a high cure rate for Type II Diabetes. For obese patients with type 2 diabetes seeking metabolic resolution as a primary outcome.
- Banda Gástrica (Gastric Band) Long-term adjustable gastric band implantation with 24-month follow-up, typically resulting in 15 to 25 kilos of weight loss. For patients seeking a reversible restrictive bariatric option.
- iBalón Secuencial (Sequential Gastric Balloon) Exclusive IMEO sequential intragastric balloon program: first 500cc balloon for 6 months followed by a second 700cc balloon, extending treatment to one year to maximize sustained weight loss. For patients seeking an extended non-surgical weight loss protocol.
- Programa Silueta Personalized diet and aesthetic treatment program for patients who want to lose between 5 kg and 28+ kg through non-bariatric methods. Combines nutritional planning with aesthetic body-contouring treatments.
- Estudio Genético de Obesidad (Obesity Genetic Study) Advanced genetic test that analyzes personal genetic markers influencing appetite control, metabolism, and weight regulation, enabling personalized obesity treatment recommendations.
- Tratamiento Farmacológico Obesidad GLP-1 Pharmacological obesity treatment using GLP-1 medications (e.g., semaglutide-based therapies) with ongoing medical management. For patients seeking non-surgical, medication-based weight loss under physician supervision.
- IMEO Academy - Formación a Cirujanos International training program (IMEO Academy) for surgeons and healthcare professionals in advanced bariatric and endoscopic surgical techniques, including the Apollo EndoSleeve method. Aimed at surgeons worldwide seeking continuing medical education.
Quantifiable outcome
- 72% of patients lost all excess weight within 5 years after gastric sleeve surgery
- +6 more outcomes
Companies that use Instituto Medico Europeo de la Obesidad
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles2 records
Instituto Medico Europeo de la Obesidad technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature7 records
Instituto Medico Europeo de la Obesidad partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Hospital Viamed Santa ElenacoreIMEO performs all surgical procedures at Hospital Viamed Santa Elena, a leading reference hospital in Spain. This partnership ensures access to well-equipped surgical facilities with latest technologies, high safety standards, and comprehensive hospital support services for patients.
- Viamed Salud GroupcoreViamed group of hospitals and medical centers, including multiple hospitals across Spain. IMEO operates within the Viamed ecosystem, sharing patient records and coordination systems with other Viamed facilities including Centro Médico Viamed Menéndez Pidal, Hospital Fátima, and multiple centers in Seville.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Instituto Medico Europeo de la Obesidad competitors and assessment
Company assessmentBroad incumbents
- Centro Médico Teknon: Quirónsalud-affiliated private hospital in Barcelona offering bariatric and metabolic surgery as part of broader specialty care; comparable in Spain for high-end obesity surgery patients.
- Cleveland Clinic Bariatric & Metabolic Institute: Internationally recognized multidisciplinary bariatric center offering surgical, endoscopic, and medical weight management — comparable to IMEO in outcome-driven, multidisciplinary positioning and academic/training activities.
- Quirónsalud Obesity Units: Spain's largest private hospital group runs bariatric and metabolic surgery units across its network; competes with IMEO on access to hospital-grade obesity care across Spain.
- Hospital HM Sanchinarro: Madrid-based private hospital network that performs bariatric surgery within a broader multi-specialty portfolio; competes with IMEO's surgical offering from an incumbent hospital position in Madrid.
Regional players
- Obesity Control Center: Specialty bariatric surgery practice in Mexico serving medical tourism patients; comparable as a competing premium bariatric destination for international obesity patients.
- Euroespes (Centro Médico Euroespes): Spanish clinical research and specialty medicine center with personalized genomic and obesity programs; comparable to IMEO's genetic-testing-led personalized obesity offering at a smaller scale.
Direct peers
- Clínica Doctor Catania: Madrid-based bariatric clinic offering gastric sleeve, bypass, and endoscopic obesity treatments — overlaps directly with IMEO's core procedure portfolio and Madrid patient base.
- New Life Bariatric Surgery (Mexico/US): Bariatric specialty clinic offering gastric sleeve, bypass, and Apollo-style endoscopic techniques with international patient flow; comparable in service mix and proprietary endoscopic procedures to IMEO.
- Beverly Hills Physicians: Multi-specialty private practice group offering bariatric surgery, gastric balloon, and GLP-1 medical weight loss — directly comparable in positioning across surgical + non-surgical + pharma obesity services.
- Clínica Obésitas: Spain-based bariatric surgery clinic offering gastric sleeve, bypass, and balloon procedures with multidisciplinary follow-up — directly comparable Spanish specialty obesity competitor to IMEO.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Instituto Medico Europeo de la Obesidad social profiles
Digital presenceInstituto Medico Europeo de la Obesidad financial estimates
Financial estimateRevenue estimate
Valuation estimate
Instituto Medico Europeo de la Obesidad leadership team
Management profileNumber of profiles
Instituto Medico Europeo de la Obesidad funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Instituto Medico Europeo de la Obesidad M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Instituto Medico Europeo de la Obesidad
What does Instituto Medico Europeo de la Obesidad do?
Instituto Médico Europeo de la Obesidad (IMEO) is a specialized obesity treatment clinic offering a comprehensive portfolio of surgical and non-surgical weight loss interventions. Core services include bariatric procedures (gastric sleeve, gastric bypass, ByManga®), endoscopic treatments (Método Apollo Reforzado, iBalón Secuencial), and complementary medical, nutritional, psychological, and pharmacological (GLP-1) support programs delivered through a multidisciplinary team.
Is Instituto Medico Europeo de la Obesidad a public or private company?
Instituto Medico Europeo de la Obesidad is a private company. It is classified as unknown and is currently operating.
When was Instituto Medico Europeo de la Obesidad founded?
Instituto Medico Europeo de la Obesidad was founded in 1998. It employs 11 to 50 people.
Where is Instituto Medico Europeo de la Obesidad based?
Instituto Medico Europeo de la Obesidad is headquartered in Madrid, Spain, in the Europe region.
How does Instituto Medico Europeo de la Obesidad make money?
Four revenue lines are on record. Bariatric Surgery Services are the primary driver. The others are endoscopic Treatments, medical Consultations and pharmacological Treatment.
Who are Instituto Medico Europeo de la Obesidad's main competitors?
Broad incumbents on record are Centro Médico Teknon, Cleveland Clinic Bariatric & Metabolic Institute, Quirónsalud Obesity Units and Hospital HM Sanchinarro. Regional players are Obesity Control Center and Euroespes (Centro Médico Euroespes). Direct peers are Clínica Doctor Catania, New Life Bariatric Surgery (Mexico/US), Beverly Hills Physicians and Clínica Obésitas.
Does Instituto Medico Europeo de la Obesidad have an API?
No public API is recorded for Instituto Medico Europeo de la Obesidad.
What industry is Instituto Medico Europeo de la Obesidad in?
Instituto Medico Europeo de la Obesidad's product category is Bariatric Surgery & Obesity Treatment Services. Its primary akta.pro industry code is HLAKADAL, Obesity Medicine & Weight Management, with a secondary code of HSADAFAB, Weight Loss Coaching (Non-Clinical). Its NAICS code is 812191 and its SIC code is 8093.